GUSB Pseudogene 11 is promising as a therapeutic target for CRC, but because of the relatively small sample size, the actual therapeutic effects of GUSBP11 on CRC need to be investigated on a larger scale. This evidence concerns the gene GUSBP11 and colorectal carcinoma.